Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Genetics of Respiratory Failure in Bronchiolitis

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
UConn Health
Information provided by (Responsible Party):
Christopher Carroll, MD, Connecticut Children's Medical Center
ClinicalTrials.gov Identifier:
NCT01271491
First received: November 9, 2010
Last updated: January 31, 2017
Last verified: January 2017

November 9, 2010
January 31, 2017
November 2010
April 2018   (Final data collection date for primary outcome measure)
The primary end point is respiratory failure. [ Time Frame: 2 years ]
Same as current
Complete list of historical versions of study NCT01271491 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Genetics of Respiratory Failure in Bronchiolitis
The Genetics of Respiratory Failure in Bronchiolitis
Bronchiolitis is a potentially severe infection of the airway in infants and children, and among the most frequent diagnoses leading to pediatric intensive care unit admission in infants. This acute infection is caused by an array of viruses, but respiratory syncytial virus (RSV) is the most frequently implicated. The majority of infants hospitalized with bronchiolitis are previously healthy, and half of infants intubated and mechanically ventilated for respiratory failure due to RSV bronchiolitis have no previously identified risk factors. It is likely, therefore, that other factors, particularly genetic heterogeneity of the host, contribute to disease severity. However, no previous study has investigated the association of genetic variants with respiratory failure in children with bronchiolitis. Several categories of candidate genes have emerged as potentially important in the pathogenesis of the disease. Specifically, genetic polymorphisms of surfactants, pattern recognition receptors, receptor adhesion molecules, and cytokines have been examined. The aim is to evaluate these polymorphisms to determine their association with respiratory failure in a cohort of more severely ill children with bronchiolitis.

We propose to conduct a prospective observational study of infants and children admitted with bronchiolitis to determine if genetic polymorphisms in a number of likely candidate immune response related genes are positively associated with respiratory failure in this population. Respiratory failure will be defined as requiring intubation and mechanical ventilation. We plan to enroll two groups of children, those admitted to the ICU with respiratory failure due to bronchiolitis (cases) and those children admitted to the ward with less severe bronchiolitis infection (controls). In special circumstances, we will also enroll pairs of twins who are hospitalized with bronchiolitis (in the ICU or the ward), for whom either one or both twins do not meet inclusion criteria as a case or a control and/or for whom we are not able to obtain a DNA blood sample while hospitalized (twin inpatient population).

Demographic data, and data regarding the hospital treatments and course of these children will be collected. Blood, saliva or sputum for genotyping will also be obtained. If a patient enrolled as a control needs to be intubated, these children cannot be control patients, but instead would be considered cases.

We propose to compare a population of 100 children with respiratory failure due to bronchiolitis to a population of 100 children with bronchiolitis without respiratory failure. Clinical characteristics and genetic markers will be compared. We will also compare clinical characteristics and genetic markers of any twin pairs who are enrolled.

Observational
Observational Model: Case-Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Saliva and blood
Probability Sample
Children hospitalized with bronchiolitis
Bronchiolitis
Not Provided
  • Cases
    Children hospitalized in the ICU with bronchiolitis
  • Controls
    Children hospitalized in the general ward with bronchiolitis
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
174
October 2018
April 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria, cases:

  • admission to the ICU with a primary diagnosis of bronchiolitis
  • endotracheally intubated and mechanically ventilated with respiratory failure due to bronchiolitis
  • age less than 2 years

Exclusion Criteria, cases:

  • pre-existing chronic disease including:

    1. bronchopulmonary dysplasia
    2. congenital heart disease
    3. immune deficiency
  • requiring an additional venopuncture for blood collection for genotyping

Inclusion Criteria, controls:

  • admission to the hospital with a primary diagnosis of bronchiolitis
  • age less than 2 years

Exclusion Criteria, controls:

  • pre-existing chronic disease including:

    1. bronchopulmonary dysplasia
    2. congenital heart disease
    3. immune deficiency
  • requiring an additional venopuncture for blood collection for genotyping
  • requiring non-invasive positive pressure ventilation or high flow nasal cannula
  • requiring intubation and mechanical ventilation during the hospitalization
Sexes Eligible for Study: All
up to 2 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01271491
10-097
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
No
Not Provided
Christopher Carroll, MD, Connecticut Children's Medical Center
Connecticut Children's Medical Center
UConn Health
Principal Investigator: Christopher L Carroll, MD, MS Connecticut Children's Medical Center
Connecticut Children's Medical Center
January 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP